RHUMBLINE ADVISERS - FIBROGEN INC ownership

FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 194 filers reported holding FIBROGEN INC in Q1 2020. The put-call ratio across all filers is 1.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of FIBROGEN INC
ValueSharesWeighting
Q3 2023$133,391
-69.8%
154,587
-5.4%
0.00%
Q2 2023$441,153
+17674.1%
163,390
+22.8%
0.00%
-100.0%
Q1 2023$2,482
+21.2%
133,006
+4.1%
0.00%0.0%
Q4 2022$2,048
-99.9%
127,822
+2.2%
0.00%
+50.0%
Q3 2022$1,627,000
+36.7%
125,069
+10.9%
0.00%0.0%
Q2 2022$1,190,000
-0.8%
112,727
+13.0%
0.00%0.0%
Q1 2022$1,199,000
-18.4%
99,737
-4.2%
0.00%0.0%
Q4 2021$1,469,000
+38.6%
104,160
+0.4%
0.00%
+100.0%
Q3 2021$1,060,000
-62.6%
103,748
-2.6%
0.00%
-75.0%
Q2 2021$2,837,000
-19.2%
106,527
+5.3%
0.00%
-20.0%
Q1 2021$3,511,000
-15.7%
101,155
-9.9%
0.01%
-16.7%
Q4 2020$4,163,000
-12.0%
112,234
-2.4%
0.01%
-14.3%
Q3 2020$4,728,000
-18.9%
114,971
-20.1%
0.01%
-30.0%
Q2 2020$5,833,000
+33.5%
143,907
+14.4%
0.01%
+11.1%
Q1 2020$4,370,000
-19.3%
125,748
-0.4%
0.01%0.0%
Q4 2019$5,417,000
+21.1%
126,304
+4.4%
0.01%
+12.5%
Q3 2019$4,473,000
-19.7%
120,962
-1.9%
0.01%
-20.0%
Q2 2019$5,569,000
-7.3%
123,253
+11.5%
0.01%
-16.7%
Q1 2019$6,009,000
+16.3%
110,563
-1.0%
0.01%
+9.1%
Q4 2018$5,169,000
+18.4%
111,700
+55.4%
0.01%
+37.5%
Q3 2018$4,367,000
-12.2%
71,888
-9.5%
0.01%
-20.0%
Q2 2018$4,974,000
+53.5%
79,461
+13.3%
0.01%
+42.9%
Q1 2018$3,240,000
-3.0%
70,126
-0.5%
0.01%0.0%
Q4 2017$3,341,000
-23.8%
70,488
-13.5%
0.01%
-30.0%
Q3 2017$4,386,000
+99.2%
81,521
+19.6%
0.01%
+100.0%
Q2 2017$2,202,000
+46.0%
68,167
+11.4%
0.01%
+25.0%
Q1 2017$1,508,000
+24.0%
61,181
+7.7%
0.00%
+33.3%
Q4 2016$1,216,000
+12.8%
56,809
+9.1%
0.00%0.0%
Q3 2016$1,078,000
+28.9%
52,088
+2.3%
0.00%
+50.0%
Q2 2016$836,000
-14.8%
50,918
+10.5%
0.00%
-33.3%
Q1 2016$981,000
-29.9%
46,090
+0.3%
0.00%
-40.0%
Q4 2015$1,400,000
+51.2%
45,940
+8.7%
0.01%
+66.7%
Q3 2015$926,000
-2.8%
42,265
+4.3%
0.00%0.0%
Q2 2015$953,000
+376.5%
40,535
+535.3%
0.00%
+200.0%
Q1 2015$200,0006,3800.00%
Other shareholders
FIBROGEN INC shareholders Q1 2020
NameSharesValueWeighting ↓
Vantage Consulting Group Inc 605,713$9,703,5225.73%
ARMISTICE CAPITAL, LLC 3,864,000$61,901,2801.08%
Logos Global Management LP 525,000$8,410,5000.98%
5AM Venture Management, LLC 225,583$3,613,8400.97%
Intercontinental Wealth Advisors, LLC 191,300$3,064,6260.91%
BHK Investment Advisors, LLC 87,550$1,402,5510.79%
Integral Health Asset Management, LLC 175,000$2,803,5000.59%
Nan Fung Group Holdings Ltd 34,106$546,3780.38%
Soleus Capital Management, L.P. 113,463$1,817,6770.26%
Point72 Asset Management, L.P. 4,781,645$76,601,9530.26%
View complete list of FIBROGEN INC shareholders